PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8422666-2	1993	Here we characterize the rIL-2 requirements for the generation of enhanced antitumor cytotoxicity by L-PAM TuB thymocytes relative to normal thymocytes upon in vitro stimulation with MOPC-315 tumor cells.	Melphalan	101-106	tubby bipartite transcription factor	Mus musculus	107-110	
8422666-4	1993	However, even when rIL-2 was added on day 2 after culture initiation, thymocytes from L-PAM TuB mice generated a more potent antitumor cytotoxicity than did thymocytes from normal mice.	Melphalan	86-91	tubby bipartite transcription factor	Mus musculus	92-95	
8422666-7	1993	The same low concentration of rIL-2 was also sufficient for restoring the generation of antitumor cytotoxicity by cultures of L-PAM TuB thymocytes, but not normal thymocytes, from which the rIL-2-containing medium was removed 1 day earlier.	Melphalan	126-131	tubby bipartite transcription factor	Mus musculus	132-135	
8422666-8	1993	At the same time, conditioned medium from stimulation cultures of L-PAM TuB thymocytes was not superior to conditioned medium from stimulation cultures of normal thymocytes in supporting the generation of antitumor cytotoxicity by either normal or L-PAM TuB thymocytes.	Melphalan	66-71	tubby bipartite transcription factor	Mus musculus	72-75	
1760820-3	1991	In addition, the ability of melphalan TuB thymocytes to generate an enhanced level of anti-MOPC-315 cytotoxicity correlated with their ability to proliferate more readily than thymocytes from untreated tumor-bearing mice and thymocytes from untreated or melphalan-treated normal mice in response to stimulation with MOPC-315 tumor cells plus a low concentration of rIL-2.	Melphalan	28-37	tubby bipartite transcription factor	Mus musculus	38-41